跳至主要内容
临床试验/CTRI/2024/08/072615
CTRI/2024/08/072615已完成3 期

Prospective single arm open clinical trial to study the efficacy of Mutrakricchahar Ghanvati in mutrakrichha with special reference to urinary tract infection.

Dr pradnya govardhan kashid1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年9月7日最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
to evaluate the efficacy of mutrakricchar ghanvati in the managment of mutrakriccha

研究概览

简要总结

single arm open clinical trial

this study is conducting for evaluate efficacy of mutrakricchahar ghanvati in the management of mutrakriccha with special referance to urinary tract infection

after screening patients at OPD and IPD level 30 patients will be selected for trial, informed written consent will be taken in native langauge

Mutra refers to the urine and Krichrata refers to difficulty, hence disease Mutrakrichha  include those forms of urinary disorders where Krichrata i.e. difficulty in the normal flow of urine is Dominant feature so all kinds of dysuria can be considered under this group. Urinary Tract Infection is one of the most common and potentially serious bacterial infection found Globally. It is common disorder accounting for 1-3% of consultations in general medical practice. According to Pub Med Central Article, Latest Prevalence rate of urinary tract infections are 10.1%. Where as, in Davidson’s principle and Practice for Medicine, it is about 37% .It is estimated that 40% women reported having UTI throughout their life. Typical features of UTI include frequency, urgency, dysuria, suprapubic pain during and after voiding, Urine appears cloudy, intense desire to pass more urine after micturition due to spasm of the inflammed bladder wall.

Null hypothesis-

Mutrakricchahar Ghanvati 500mg orally two tablets twice a day for 14 days is not effective in Mutrakriccha with special reference to UTI.

Alternate****hypothesis

Mutrakricchahar Ghanvati 500mg orally two tablets twice a day for 14 days is effective in Mutrakriccha with special reference to UTI.

Drug – Mutrakricchahar Ghanvati

● Dose – 500 mg 2 tablets Twice a day

● Anupana – Koshna Jala

● Sevan Kala – Vyanodana (after food)

● Duration - 14 days

●Follow up - 7 th day , 14th day

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • 1 Patient presenting with symptoms of Mutrakriccha with Urinary Tract Infection like Peeta Mutrata (Discolouration of urine), Bahurmutrata (Frequency of Urine), Sarakta Mutrata (Haematuria), Sadaha Mutrata (burning micturition), Saruja Mutrata (Painful Micturition), described in Ayurvedic classics 2 Without any bar of caste, sex, religion, occupation, socio-economic status.
  • 3 Urine examination showing pus cells upto 30/hpf & RBC’s upto 15/hpf.

排除标准

  • 1 Pregnant and lactating mothers.
  • 2 Patients with serious illness like HJV, malignancy, Severe Cardiac disease, Uncontrolled stage at HTN.
  • 3 Pt having Auto Immune disorders.

结局指标

主要结局

to evaluate the efficacy of mutrakricchar ghanvati in the managment of mutrakriccha

时间窗: 7th day, 14th day

次要结局

  • 1 To evaluate the effect of Mutrakricchahar Ghanvati in Mutrakrichha(2 To Study the etiopathology of Mutrakrichha)

研究者

发起方
Dr pradnya govardhan kashid
申办方类型
Other [self ]
责任方
Principal Investigator
主要研究者

Dr Pradnya Govardhan Kashid

Seth Chandanmal Mutha Aryangla Vaidyak Mahavidyalaya , Satara

研究点 (1)

Loading locations...

相似试验